Skip to main content
Top
Published in: Journal of Artificial Organs 2/2013

Open Access 01-06-2013 | Original Article

The effect of vitamin E-bonded polysulfone membrane dialyzer on a new oxidative lipid marker

Authors: Yuki Kitamura, Kumi Kamimura, Noriko Yoshioka, Yoko Hosotani, Kenji Tsuchida, Masahide Koremoto, Jun Minakuchi

Published in: Journal of Artificial Organs | Issue 2/2013

Login to get access

Abstract

The use of vitamin E-bonded cellulose membrane dialyzers has been reported to cause a decrease in oxidative lipid marker levels (Nakai et al., Ther Apher Dial 14:505–540, 1; Nakai et al., J Jpn Soc Dial Ther 45:1–47, 2; Mashiba et al., Arterioscler Thromb Vasc Biol 21:1801–1808, 3). However, few studies have identified this effect with vitamin E-bonded polysulfone membranes, and no studies report the same effect on alpha (1) antitrypsin–LDL complex, a new oxidative lipid marker. This prompted us to examine the influence of use of VPS-HA vitamin E-bonded polysulfone high-flux membrane dialyzers on this new oxidative lipid marker. The subjects were 17 patients who had been dialyzed with VPS-HA for 12 months. The subjects’ baseline characteristics were as follows. Their average age was 65.6 ± 13.1 years, comprising 8 males and 9 females; hemodialysis vintage was 83.8 ± 85.4 months. Eight had chronic glomerular nephropathy and five had diabetic nephropathy. The primary outcome was defined as alpha (1) antitrypsin–LDL complex level after 12 months, as a post-study using VPS-HA. Secondary outcomes included triglycerides, total cholesterol, HDL cholesterol and LDL cholesterol levels. The data were analyzed pre-study and after 3, 6, 9 and 12 months for alpha (1) antitrypsin–LDL complex, and pre-study and post-study for the other indicators. Twelve months after switching to VPS-HA, alpha (1) antitrypsin–LDL complex, total cholesterol and LDL cholesterol had significantly decreased. Triglycerides and HDL cholesterol had not significantly changed. Hemodialysis therapy with VPS-HA was shown to decrease alpha (1) antitrypsin–LDL complex, an index of oxidative stress, and also to decrease some lipid markers.
Literature
1.
go back to reference Nakai S, Suzuki K, Masakane I, Wada A, Itami N, Ogata S, Kimata N, Shigematsu T, Shinoda T, Syouji T, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Marubayashi S, Morita O, Yamagata K, Wakai K, Watanabe Y, Iseki K, Tsubakihara Y. Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial. 2010;14:505–40.PubMedCrossRef Nakai S, Suzuki K, Masakane I, Wada A, Itami N, Ogata S, Kimata N, Shigematsu T, Shinoda T, Syouji T, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Marubayashi S, Morita O, Yamagata K, Wakai K, Watanabe Y, Iseki K, Tsubakihara Y. Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial. 2010;14:505–40.PubMedCrossRef
2.
go back to reference Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, Shigematsu T, Shinoda T, Shoji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Masakane I, Marubayashi S, Morita O, Yamagata K, Wakai K, Wada A, Watanabe Y, Tsubakihara Y. An overview of regular dialysis treatment in Japan (as of 31 December 2010) J Jpn Soc Dial Ther. 2012;45:1–47 (in Japanese). Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, Shigematsu T, Shinoda T, Shoji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Masakane I, Marubayashi S, Morita O, Yamagata K, Wakai K, Wada A, Watanabe Y, Tsubakihara Y. An overview of regular dialysis treatment in Japan (as of 31 December 2010) J Jpn Soc Dial Ther. 2012;45:1–47 (in Japanese).
3.
go back to reference Mashiba S, Wada Y, Takeya M, Sugiyama A, Hamakubo T, Nakamura A, Noguchi N, Niki E, Izumi A, Kobayashi M, Uchida K, Kodama T. In vivo complex formation of alpha 1—antitrypsin and LDL. Arterioscler Thromb Vasc Biol. 2001;21:1801–8.PubMedCrossRef Mashiba S, Wada Y, Takeya M, Sugiyama A, Hamakubo T, Nakamura A, Noguchi N, Niki E, Izumi A, Kobayashi M, Uchida K, Kodama T. In vivo complex formation of alpha 1—antitrypsin and LDL. Arterioscler Thromb Vasc Biol. 2001;21:1801–8.PubMedCrossRef
4.
go back to reference Kuragano T, Kida A, Itoh K, Furuta A, Yamamoto S, Tokuyama M, Hata R, Nanami M, Otaki Y, Hasuike Y, Izumi M, Nakanishi T. The anti-oxidant effect of acetate-free-biofiltration (AFB) with vitamin E coated polysulfone membrane (VPS). Vitamembrane. 2008;8:35–40 (in Japanese). Kuragano T, Kida A, Itoh K, Furuta A, Yamamoto S, Tokuyama M, Hata R, Nanami M, Otaki Y, Hasuike Y, Izumi M, Nakanishi T. The anti-oxidant effect of acetate-free-biofiltration (AFB) with vitamin E coated polysulfone membrane (VPS). Vitamembrane. 2008;8:35–40 (in Japanese).
5.
go back to reference Amore A, Cirina P, Bonaudo R, Conti G, Chiesa M, Coppo R. Bicarbonate dialysis, unlike acetate-free biofiltration, triggers mediators of inflammation and apoptosis in endothelial and smooth muscle cells. J Nephrol. 2006;19:57–64.PubMed Amore A, Cirina P, Bonaudo R, Conti G, Chiesa M, Coppo R. Bicarbonate dialysis, unlike acetate-free biofiltration, triggers mediators of inflammation and apoptosis in endothelial and smooth muscle cells. J Nephrol. 2006;19:57–64.PubMed
6.
go back to reference Amore A, Cirina P, Mitola S, Peruzzi L, Bonaudo R, Gianoglio B, Coppo R. Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol. 1997;8:1431–6.PubMed Amore A, Cirina P, Mitola S, Peruzzi L, Bonaudo R, Gianoglio B, Coppo R. Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol. 1997;8:1431–6.PubMed
7.
go back to reference Satoh M, Yamasaki Y, Nagake Y, Kasahara J, Hashimoto M, Nakanishi N, Makino H. Oxidative stress is decreased by the long-term use of vitamin E coated dialysis filters. Kidney Int. 2001;59:1943–50.PubMedCrossRef Satoh M, Yamasaki Y, Nagake Y, Kasahara J, Hashimoto M, Nakanishi N, Makino H. Oxidative stress is decreased by the long-term use of vitamin E coated dialysis filters. Kidney Int. 2001;59:1943–50.PubMedCrossRef
8.
go back to reference Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583–95.PubMed Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583–95.PubMed
9.
go back to reference Matsumoto Y. Vitamin E-bonded polysulfone membrane dialyzer. In: Takezawa S, Arakawa M, Fukuda M, editors. High performance dialyzer, vol. 1; 2008. p. 71–6 (in Japanese). Matsumoto Y. Vitamin E-bonded polysulfone membrane dialyzer. In: Takezawa S, Arakawa M, Fukuda M, editors. High performance dialyzer, vol. 1; 2008. p. 71–6 (in Japanese).
10.
go back to reference Naito Y. Radical oxygen species (ROS). In: Kurabayashi M, Yamagishi S, editors. Oxidative stress navigator, vol. 1; 2005. p. 28–9 (in Japanese). Naito Y. Radical oxygen species (ROS). In: Kurabayashi M, Yamagishi S, editors. Oxidative stress navigator, vol. 1; 2005. p. 28–9 (in Japanese).
11.
go back to reference Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant. 2005;20:2775–82.PubMedCrossRef Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant. 2005;20:2775–82.PubMedCrossRef
12.
go back to reference Kotani K, Satoh N, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Yamakage H, Yamada K, Hattori M, Shimatsu A, Japan Obesity and Metabolic Syndrome Study Group. A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome. Atherosclerosis. 2009;204:526–31.PubMedCrossRef Kotani K, Satoh N, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Yamakage H, Yamada K, Hattori M, Shimatsu A, Japan Obesity and Metabolic Syndrome Study Group. A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome. Atherosclerosis. 2009;204:526–31.PubMedCrossRef
13.
go back to reference Koremoto M, Takahara N, Takahashi M, Okada Y, Satoh K, Kimura T, Hirai T, Ebihara I, Nagasaku D, Miyata S, Maniwa S, Kouzuma T, Arimura T, Kamei J. Improvement of intradialytic hypotension in diabetic hemodialysis patients using vitamin E-bonded polysulfone membrane dialyzers. Artif Organs. 2012;36:901–10.PubMedCrossRef Koremoto M, Takahara N, Takahashi M, Okada Y, Satoh K, Kimura T, Hirai T, Ebihara I, Nagasaku D, Miyata S, Maniwa S, Kouzuma T, Arimura T, Kamei J. Improvement of intradialytic hypotension in diabetic hemodialysis patients using vitamin E-bonded polysulfone membrane dialyzers. Artif Organs. 2012;36:901–10.PubMedCrossRef
Metadata
Title
The effect of vitamin E-bonded polysulfone membrane dialyzer on a new oxidative lipid marker
Authors
Yuki Kitamura
Kumi Kamimura
Noriko Yoshioka
Yoko Hosotani
Kenji Tsuchida
Masahide Koremoto
Jun Minakuchi
Publication date
01-06-2013
Publisher
Springer Japan
Published in
Journal of Artificial Organs / Issue 2/2013
Print ISSN: 1434-7229
Electronic ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-013-0689-1

Other articles of this Issue 2/2013

Journal of Artificial Organs 2/2013 Go to the issue